The Next Supreme Court Cases To Shape Patent Law

Law360, New York (January 1, 2014, 3:16 PM EST) -- The U.S. Supreme Court's patent docket has continued its steady rise over the past few terms. The court last term decided Association for Molecular Pathology v. Myriad Genetics Inc. (naturally occurring DNA patent-ineligible) and Bowman v. Monsanto Co. (exhaustion inapplicable to reproduction of patented seed), and recently heard argument in Medtronic Inc. v. Boston Scientific Corp. over the burden of proof in a patent licensee's declaratory judgment action. The court has two more patent cases on its docket involving attorney fees, and recently granted certiorari in an important patentability case, Alice Corp. v. CLS Bank International....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as